The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bi, Z.
Right arrow Articles by Reiss, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bi, Z.
Right arrow Articles by Reiss, C. S.

The Journal of Immunology, Vol 155, Issue 12 5684-5689, Copyright © 1995 by American Association of Immunologists


ARTICLES

IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system

Z Bi, P Quandt, T Komatsu, M Barna and CS Reiss
Department of Biology, Kaplan Comprehensive Cancer Center, New York University, New York 10003, USA.

To investigate the role of a cytokine in host defense against the vesicular stomatitis virus (VSV) infection of the central nervous system (CNS), IL-12 was injected i.p. into groups of 10 BALB/c mice on days -1, 0, 1, 2, and 3 postinfection. Four days postinfection, mice were examined. IL-12 strongly enhanced immunity to VSV infection in the CNS as demonstrated by 1) decreased VSV titers in brain homogenate of IL-12-injected mice compared with those of controls; 2) increased expression of inducible nitric oxide synthase in the CNS; 3) enhanced expression of both MHC class I and class II Ags in the CNS; 4) increased T cell infiltration in the CNS, especially in the olfactory bulb; and 5) diminished VSV-induced apoptosis in olfactory bulb. No detrimental effect was observed even with the 200 ng/mouse dose of IL- 12. Protective effects of IL-12 were dose dependent. Collectively, these results demonstrate that exogenously added IL-12, even when injected peripherally, significantly enhances recovery from VSV infection of the CNS.


This article has been cited by other articles:


Home page
J Clin PharmacolHome page
C. Trudeau, M. M. Cotreau, L. Stonis, K. H. Dykstra, J. L. Oestreicher, A. Strahs, A. J. Dorner, V. H. Van Cleave, W. L. Trepicchio, and U. S. Schwertschlag
A Single Administration of Recombinant Human Interleukin-12 Is Associated With Increased Expression Levels of Interferon-gamma and Signal Transducer and Activator of Transcription in Healthy Subjects
J. Clin. Pharmacol., June 1, 2005; 45(6): 649 - 658.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Smith, F. Santoro, G. Di Lullo, L. Dagna, A. Verani, and P. Lusso
Selective suppression of IL-12 production by human herpesvirus 6
Blood, October 15, 2003; 102(8): 2877 - 2884.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
J.-H. Sur, R. Allende, and A. R. Doster
Vesicular Stomatitis Virus Infection and Neuropathogenesis in the Murine Model are Associated with Apoptosis
Vet. Pathol., September 1, 2003; 40(5): 512 - 520.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. B. Flanagan, T. R. Schoeb, and G. W. Wertz
Vesicular Stomatitis Viruses with Rearranged Genomes Have Altered Invasiveness and Neuropathogenesis in Mice
J. Virol., May 15, 2003; 77(10): 5740 - 5748.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
K. J. Maloy, C. Burkhart, T. M. Junt, B. Odermatt, A. Oxenius, L. Piali, R. M. Zinkernagel, and H. Hengartner
CD4+ T Cell Subsets during Virus Infection: Protective Capacity Depends on Effector Cytokine Secretion and on Migratory Capability
J. Exp. Med., June 19, 2000; 191(12): 2159 - 2170.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. C. Pien and C. A. Biron
Compartmental Differences in NK Cell Responsiveness to IL-12 During Lymphocytic Choriomeningitis Virus Infection
J. Immunol., January 15, 2000; 164(2): 994 - 1001.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. van den Broek, M. F. Bachmann, G. Kohler, M. Barner, R. Escher, R. Zinkernagel, and M. Kopf
IL-4 and IL-10 Antagonize IL-12-Mediated Protection Against Acute Vaccinia Virus Infection with a Limited Role of IFN-{gamma} and Nitric Oxide Synthetase 2
J. Immunol., January 1, 2000; 164(1): 371 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-I. Sin, J. J. Kim, R. L. Arnold, K. E. Shroff, D. McCallus, C. Pachuk, S. P. McElhiney, M. W. Wolf, S. J. Pompa-de Bruin, T. J. Higgins, et al.
IL-12 Gene as a DNA Vaccine Adjuvant in a Herpes Mouse Model: IL-12 Enhances Th1-Type CD4+ T Cell-Mediated Protective Immunity Against Herpes Simplex Virus-2 Challenge
J. Immunol., March 1, 1999; 162(5): 2912 - 2921.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Aloisi, G. Penna, E. Polazzi, L. Minghetti, and L. Adorini
CD40-CD154 Interaction and IFN-{gamma} Are Required for IL-12 But Not Prostaglandin E2 Secretion by Microglia During Antigen Presentation to Th1 Cells
J. Immunol., February 1, 1999; 162(3): 1384 - 1391.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. M. Monteiro, C. Harvey, and G. Trinchieri
Role of Interleukin-12 in Primary Influenza Virus Infection
J. Virol., June 1, 1998; 72(6): 4825 - 4831.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Fernandez-Sesma, R. W. Peluso, X. Bai, J. L. Schulman, D. E. Levy, and T. M. Moran
Superantigen-Activated T Cells Redirected by a Bispecific Antibody Inhibit Vesicular Stomatitis Virus Replication In Vitro and In Vivo
J. Immunol., February 15, 1998; 160(4): 1841 - 1849.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.